Literature DB >> 26612006

Microbiological diagnosis of Eggerthella lenta blood culture isolates in a Swedish tertiary hospital: Rapid identification and antimicrobial susceptibility profile.

Karin Liderot1, Paul Ratcliffe1, Petra Lüthje1, Ellinor Thidholm1, Volkan Özenci2.   

Abstract

Eggerthella lenta is a Gram-positive anaerobic bacillus. Improved diagnostics and increased awareness of rare pathogens have revealed its potential to cause serious invasive infections. In this study, 18 clinical E. lenta isolates derived from positive blood cultures were included. Underlying problems of the patients were in the majority of cases related to the gastrointestinal tract. The performance of two MALDI-TOF MS systems, i.e. Bruker and Vitek MS, in identification of E. lenta was analyzed. In addition, the minimal inhibitory concentrations for clinically relevant antimicrobial agents were determined by routine procedures using E-test. 17 of the 18 E. lenta isolates investigated in this study were correctly identified to species level by the Bruker MS system, while the Vitek MS system identified all 18 isolates. Antimicrobial sensitivity towards the tested agents was in general good. However, high resistance rates were observed for penicillin G and piperacillin-tazobactam based on EUCAST breakpoints.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaerobic bacteria; Antimicrobial susceptibility testing; Blood culture; Etest; MALDI-TOF MS; Vitek

Mesh:

Substances:

Year:  2015        PMID: 26612006     DOI: 10.1016/j.anaerobe.2015.11.005

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  6 in total

1.  Sepsis caused by Eggerthelle lenta: a case report.

Authors:  Li-Chao Sun; Wan-Ling Xu; Jian-Nan Chai; Li Pang; Xiu-Xian Zang; Wei Li; Ji-Hong Xing
Journal:  World J Emerg Med       Date:  2022

2.  Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Kyoungmi Jung; Areum Kim; Ji-Hae Lee; Donghyun Cho; Juyeon Seo; Eun Sung Jung; Hye-Ji Kang; Jonghwa Roh; Wangi Kim
Journal:  Nutrients       Date:  2022-05-11       Impact factor: 6.706

3.  Identification and Antibiotic Susceptibility of Eggerthella lenta in Bloodstream Infections.

Authors:  Xiangyun Li; Enjun Xu; Cuixiao Shi; Guanhua Qiao; Shuyi Chen; Yuanhong Xu; Yajing Liu; Xundi Bao
Journal:  Pol J Microbiol       Date:  2022-06-19

Review 4.  Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature.

Authors:  Shuming Jiang; Jianfei E; Dengchao Wang; Yanjiao Zou; Xiao Liu; Hualiang Xiao; Yuan Wen; Zongyao Chen
Journal:  Eur J Med Res       Date:  2021-09-20       Impact factor: 2.175

Review 5.  Determination and Identification of Antibiotic Drugs and Bacterial Strains in Biological Samples.

Authors:  Katarzyna Pauter; Małgorzata Szultka-Młyńska; Bogusław Buszewski
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

6.  Lactobacillus plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double-Blind, Randomized, Placebo-Controlled Study.

Authors:  Bo Yang; Yue Yue; Yang Chen; Mengfan Ding; Bowen Li; Linlin Wang; Qun Wang; Catherine Stanton; R Paul Ross; Jianxin Zhao; Hao Zhang; Wei Chen
Journal:  Front Immunol       Date:  2021-10-15       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.